Rick Bright ✓

@RickABright · Washington, DC · joined 20 Jan 2017

Practical, Innovative, Hyper-focused on saving lives. Immunologist, Virologist, Pandemic Nemesis. Posts are mine.

49 144Followers

3 012Following

11 299Posts total

68.3KViews on collected posts

Against accounts of the same size

11 posts from the last 90 days, next to the 10K–100K follower range. right around the median for its follower range.

Median views3 018this account1 756median for 10K–100K

Reach, %6.14%this account5.38%median for 10K–100K

Engagement, %1.52%this account1.75%median for 10K–100K

Metric	This account	Median for 10K–100K	Ratio
Median views per post	3 018	1 756	1.72×
Reach (views ÷ followers)	6.14%	5.38%	1.14×
Engagement rate	1.52%	1.75%	0.87×

Others in this range → Compare with another account → How these benchmarks are built →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

6.1K6 Jul

4.8K7 Jul

5.1K

2.2K6 Aug

27.7K24 Aug

65425 Aug

413

12.4K26 Aug

2.9K

Last 11 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

0.57%6 Jul

1.55%7 Jul

1.52%

0.55%

1.08%6 Aug

1.16%24 Aug

2.29%25 Aug

0.73%

6.95%

2.64%26 Aug

4.42%

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.75%.

What the audience does

Likes70.8%918 in total

Reposts15.0%194 in total

Replies5.4%70 in total

Quotes1.9%25 in total

Bookmarks6.9%89 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.

Latest posts

Leadership & Compassion @DollyParton 2.9K views · 116 likes · 12 reposts · 1 replies 26 Aug 2026 “Don’t be such a chicken squat. Get out there and get your shot.” -- Dolly Parton Dolly Parton didn't just use her voice to encourage vaccination, she helped support the science behind it. In April 2020, Dolly donated US$1 million to Vanderbilt University Medical Center for h 12.4K views · 213 likes · 62 reposts · 41 replies 26 Aug 2026 @RickABright After you've organised DARPA to spread this around a bit are you guys going to stop doctors giving the elderly antibiotics for pneumonia like you did last time, until they are forced into taking an experimental vaccine so your friends get paid lots? Asking for 8bn p 3K views · 167 likes · 34 reposts · 4 replies 25 Aug 2026 @RickABright “This is a laboratory biosafety and manufacturing quality-control story, not a consumer exposure story. No pasteurized dairy product, retail meat item, or medical treatment is implicated. The people whose practices may change are diagnosticians, cell culture technici 413 views · 3 likes · 0 reposts · 0 replies 25 Aug 2026 @RickABright Yikes! That pushes a lot of BSL1/2 work right into BSL3. 😬 Every lot will have to be tested. 654 views · 12 likes · 2 reposts · 1 replies 25 Aug 2026 This is a very important and very concerning finding. 27.7K views · 251 likes · 53 reposts · 9 replies 24 Aug 2026 Science moves forward Less than a year ago, I argued in @nytopinion that mRNA technology represented far more than a COVID vaccine—it's a platform for responding to future biological threats Yesterday's FDA approval of the first mRNA influenza vaccine is another important step 2.2K views · 22 likes · 2 reposts · 0 replies 06 Aug 2026 Competent reform also requires regular leadership renewal, fresh external perspectives, and governance structures that reward mission impact, transparency, and public trust. NIAID’s next chapter should strengthen discovery, accelerate translation, modernize clinical trials, and 5.1K views · 18 likes · 5 reposts · 3 replies 07 Jul 2026 Encouraging data from a unique vaccine delivery platform. Safety profile looks promising. Looking forward to efficacy data soon. H/t @Vaxart & partners. Keep going. 3K views · 33 likes · 10 reposts · 1 replies 07 Jul 2026 🚨📢Vaxart has reported topline safety and efficacy data for their oral COVID-19 vaccine candidate from a 400-person sentinel cohort in their phase 2b trial. These results are a long time coming, after many delays (some of which were absolutely not Vaxart’s fault, eg. temporary h 4.8K views · 59 likes · 9 reposts · 5 replies 07 Jul 2026 As we enter the second half of 2026, I believe the next phase for NIAID should be competent reform: stronger translational science, better clinical trials, faster therapeutics, transparent governance of risky pathogen research, and a renewed commitment to public trust. 6.1K views · 24 likes · 5 reposts · 5 replies 06 Jul 2026